We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.55 | 0.50 | 0.60 | 0.55 | 0.55 | 0.55 | 19,664 | 07:45:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 12.01M | -509k | -0.0005 | -11.00 | 5.13M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/11/2021 09:13 | POST REMOVED | buywell3 | |
12/11/2021 09:00 | POST REMOVED | buywell3 | |
05/11/2021 09:19 | POST REMOVED | buywell3 | |
05/11/2021 08:48 | Look at the last few years of history. Always promising "trials" and "evaluations", new product distribution rights, etc etc. But at the end of the day, no concrete orders. | boonkoh | |
04/11/2021 22:11 | POST REMOVED | buywell3 | |
03/11/2021 18:52 | About time we had some news. Plenty of money sloshing around in the NHS now . Is that out main hope or do we look to USA for significant orders ? Getting fed up waiting for this to finally take off. | kenone | |
25/9/2021 09:14 | I haven't a clue what they're up to but seeing as they champion resposability and surgical tooling, they already have tooling ip, and seeing that nothing will turn back the tide of robotic procedures, it wouldn't surprise me if they are investigating robotic tooling | mandate | |
24/9/2021 21:33 | POST REMOVED | buywell3 | |
24/9/2021 09:16 | Hopefully they're working on resposable robotic tooling/standards | mandate | |
24/9/2021 06:11 | POST REMOVED | buywell3 | |
21/9/2021 22:03 | A few years ago this was a speculative share with a lot of promise and I was fortunate to ride the wave when the share price climbed to 11p plus. Today I see it as a totally unexciting stock which is unlikely to provide any new investor(s) with a return on their investment. I had hoped that AMS would make an offer and relieve me of the remaining shares I hold in this company but I now think it unlikely. | john148 | |
17/9/2021 20:00 | I wasn't able to listen in live, but just listened to the recording. I thought it was comforting enough. | gnnmartin | |
16/9/2021 20:21 | I thought it was good. Increasing penetration in USA. Winning new hospitals also new rf product on varicose veins to start selling in October targeting a 6m UK market.Lots going on. | jmf69 | |
16/9/2021 16:25 | Presentation just ended. Left me rather uninspired. Possible jam tomorrow. Don't think I'll be adding to my holding just yet . | kenone | |
15/9/2021 06:47 | POST REMOVED | buywell3 | |
15/9/2021 06:09 | POST REMOVED | buywell3 | |
14/9/2021 23:29 | POST REMOVED | buywell3 | |
14/9/2021 15:56 | Results tomorrow | jmf69 | |
07/9/2021 22:39 | Surely some of the cash being thrown at the NHS should eventually trickle down to SUN! | dan de lion | |
07/7/2021 09:11 | The US clinical trial for LiquiBandFix8(R) continues to progress well with more than 80% of required patient procedures now complete and Premarket Approval (PMA) filing on track for 2022 after the 12 month patient follow up.Great news for us | jmf69 | |
02/7/2021 14:32 | 'Positive' AGM statements all very encouraging, but have they made any actual new sales / contract wins recently ? | kenone | |
02/7/2021 14:29 | Getting in need of a trading update . Looks like some getting concerned and selling out ? Biggish trade at 2.8 today. | kenone | |
23/6/2021 06:52 | POST REMOVED | buywell2 | |
22/6/2021 08:30 | https://twitter.com/ | jmf69 | |
22/6/2021 06:53 | POST REMOVED | buywell2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions